However, the protective effect of the female sex on COVID-19 outcomes, attributed to genetic factors (ACE2 gene location in the X chromosome), immunologic privilege, and hormonal benefits (estrogen) [12], may be compromised by obesity, as we observed in our study. This evidence concerns the gene ACE2 and obesity due to melanocortin 4 receptor deficiency.